Alexza Pharmaceuticals (NASDAQ:ALXA) will report earnings after markets close on Tuesday, May 14th. Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of proprietary products for the treatment of acute and intermittent conditions.
Here is your Cheat Sheet to Alexza Pharmaceuticals Earnings:
Earnings Expectations: Analysts expect earnings of $-0.45 per share on revenues of $1,000.00K.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a loss of $0.56 to a loss $0.44. For the current year, the average estimate is a loss of $1.68, which is worse than the estimate ninety days ago.
Here’s how Alexza Pharmaceuticals has been performing on an annual basis:
|Revenue ($) in millions||0.49||9.51||42.88||5.66||4.07|
|Diluted EPS ($)||-18.10||-26.80||-0.27||-5.97||-2.24|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||1.88||1.88||0.73||0.73||0.73|
|Diluted EPS ($)||-1.343||-0.40||-0.58||-0.52||-0.6541|
Alexza Pharmaceuticals has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)